Delivery Order SPE2DB20D3103-SPE2DB24FP2P8

Award Date 6/21/24
Potential Completion Date 7/15/24
Potential Value $36K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $15,017.50 order is for TRODELVY 180 MG VIALS, a specialty pharmaceutical product. The delivery order was not set aside for any specific business type. Amerisourcebergen Drug Corp is the prime contractor and has been awarded numerous pharmaceutical and medical supply contracts...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $18,021.00 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product TRODELVY 180 MG VIALS. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a period of performance through December 31, 2025. The IDC serves as the primary...
The U.S. Defense Logistics Agency (DLA) awarded a $12,014 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 180 mg vials of the drug TRODELVY. This delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical, which provides a comprehensive range of medical commodities to support military treatment programs and facilities worldwide....
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $9,010.50 to Amerisourcebergen Drug Corp, the prime contractor, to provide 180 mg vials of the pharmaceutical drug TRODELVY. The contract has a completion date of March 7, 2024 and was awarded on February 14, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a performance period...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The award, valued at $6,007.00, is for the provision of 180 mg vials of the pharmaceutical drug TRODELVY. This is a firm fixed-price contract with a period of performance ending on July 24, 2024. The contract does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distribution company, is the prime contractor for this award. The...
This federal contract award, valued at $9,584.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TRODELVY 180 MG VIALS, a specialized pharmaceutical product. The contract has an ultimate completion date of February 7, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor and holds a significant...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of 180 mg vials of the drug TRODELVY. The order has a potential value of $6,007.00 and a performance period through March 7, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a leading global pharmaceutical sourcing and distribution company, for the supply of TRODELVY 180 MG VIALS. The contract has a potential value of $12,014.00 and a completion date of February 22, 2024. The award is not associated with any set-aside designations. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 180 mg vials of the drug TRODELVY. The contract has a firm fixed price of $6,007.00 and an ultimate completion date of August 14, 2024. It is not set aside for any special program. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distributor. The contract is for the supply of TRODELVY 180MG VIAL 1S, a specialty pharmaceutical product, with a ceiling value of $9,010.50 and a performance period through March 27, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with the DLA, valued at up to...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FP2P8
    Delivery Order

This is a $36,042.00 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TRODELVY 180 MG VIALS, a specialty pharmaceutical product. The delivery order has a period of performance through July 15, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 12:47 PM